Abstract: It discloses an iron-based montmorillonite medicine for treating hyperphosphatemia and iron deficiency anaemia, and the preparation method thereof. The medicine comprises effective ingredient iron-based montmorillonite (Fe-montmorillonite) which is obtained by soaking or eluting the medicinal montmorillonite by water soluble iron salt solution. The effective ingredient is added by pharmaceutic adjuvant or not to make medicanent which is given via gastrointestinal tract. The effective ingredient binds the phosphate in the patients' digestive tract to form insoluble matter which can be excreted from the body via the digestive tract, therefore the phosphate in the patients with chronic renal failure is reduced and the goal of treating hyperphosphatemia is achieved.

Abstract: The present invention provides a preparation method of hyperbranched polycarboxylic acid type copolymer cement dispersant, including: Monomer A, B and C undergo a free radical copolymerization in an aqueous medium. The molar ratio of Monomer A, Monomer B and Monomer C conforms to B/A?A?2?10 and C/(A+B?C)?0.02?0.08. Monomer A is expressed by General Formula (1), where, R1 is H or a methyl; X1?O, CH2O, CH2CH2O; m is an integer from 5 to 200. Monomer B is expressed by General Formula (2), where, R2 is H or COOM; R3 is H or CH3 and M is H, Na, K or NH4; Monomer C is expressed by General Formula (3), where, R4 is H or methyl; X2?O, CH2O, CH2CH2O; Y?CH2, CH2CH2, CH(CH3), CH2CH2CH2, CH(CH3)CH2, C(CH3)2 and n is an integer from 5 to 200.

Abstract: The present invention provides a preparation method of hyperbranched polycarboxylic acid type copolymer cement dispersant, including: Monomer A, B and C undergo a free radical copolymerization in an aqueous medium. The molar ratio of Monomer A, Monomer B and Monomer C conforms to B/A-A-2-10 and C/(A+B-C)-0.02-0.08. Monomer A is expressed by General Formula (1), where, R1 is H or a methyl; X1?O, CH2O, CH2CH2O; m is an integer from 5 to 200.

Abstract: A noise reduction system and a noise reduction method are provided. The noise reduction system comprises a uni-directional microphone, an omni-directional microphone and a signal processing module. The signal processing module comprises an adaptive noise control (ANC) unit, a main noise reduction unit and an optimizing unit. The uni-directional microphone senses a first audio source to output a first audio signal, and the omni-directional microphone senses a second audio source to output a second audio signal. The ANC unit executes an adaptive noise control to output an estimated signal according to the first audio signal and the second audio signal. The main noise reduction unit executes a main noise reduction process to output a de-noise speech signal according to the estimated signal and the second audio signal. The optimizing unit executes an optimizing process to output an optimized speech signal according to the de-noise speech signal.

Abstract: The present invention relates to a suppressing noise system applied in a mobile device, comprises: at least two microphones are used for respectively transmitting a first audio signal with noise and a second audio signal with noise; a pre-processing unit is coupled to the at least two microphones for oversampling the first and second audio signals, downsampling the sampled first and second audio signals, and then generating a first adjusted signal and a second adjusted signal; and a suppressing noise device is coupled to the pre-processing device for filtering noise in the first and second adjusted signals once again, and outputting a third audio signal.

Abstract: A noise reduction system and a noise reduction method are provided. The noise reduction system comprises a uni-directional microphone, an omni-directional microphone and a signal processing module. The signal processing module comprises an adaptive noise control (ANC) unit, a main noise reduction unit and an optimizing unit. The uni-directional microphone senses a first audio source to output a first audio signal, and the omni-directional microphone senses a second audio source to output a second audio signal. The ANC unit executes an adaptive noise control to output an estimated signal according to the first audio signal and the second audio signal. The main noise reduction unit executes a main noise reduction process to output a de-noise speech signal according to the estimated signal and the second audio signal. The optimizing unit executes an optimizing process to output an optimized speech signal according to the de-noise speech signal.

Abstract: This invention reports a drug for hyperphospheremia and its preparative method. The preparation includes active constituents, lanthanum polystyrene sulfonate, and excipients. The preparative method in the invention can be summarized as follows: Polystyrene sulfonic acid is obtained by treating polystyrene sulfosalt with hydrochloric acid, soaked or eluted with water soluble lanthanum-contained solution, and washed with water till its PH is neutral. Then, the lanthanum polystyrene sulfonate solution is washed till the superfluous La? unexchanged is washed out. Lanthanum polystyrene sulfonate is taken out and crushed to powder after being dried. The lanthanum polystyrene sulfonate, whose weight percentage of lanthanum is 14-22%, is used as active constituents to prepare gastrointestinal tract preparations together with general amount of excipients with routine preparative method.

Abstract: This invention reports a drug for hyperphospheremia and its preparative method. The preparation includes active constituents, lanthanum polystyrene sulfonate, and excipients. The preparative method in the invention can be summarized as follows: Polystyrene sulfonic acid is obtained by treating polystyrene sulfosalt with hydrochloric acid, soaked or eluted with water soluble lanthanum-contained solution, and washed with water till its PH is neutral. Then, the lanthanum polystyrene sulfonate solution is washed till the superfluous La? unexchanged is washed out. Lanthanum polystyrene sulfonate is taken out and crushed to powder after being dried. The lanthanum polystyrene sulfonate, whose weight percentage of lanthanum is 14-22%, is used as active constituents to prepare gastrointestinal tract preparations together with general amount of excipients with routine preparative method.